/

Empresas

NM

Empresas

NMS GROUP S.P.A.

Sobre qué escribimos

EconomíaOncologíaSaludSanidadUniversidad

33 Comunicados de prensa

Ver todos los comunicados de prensa

Press Release cover image

12/01/2026

Salud

Sanidad

Nerviano Medical Sciences announces NMPA Clearance of IND for PARP7-Selective Inhibitor Atamparib in Promising New Therapeutic Setting - NMS Group

Fuente

NMS GROUP S.P.A.

1.00

0

Press Release cover image

17/11/2025

Salud

Oncología

Sanidad

Nerviano Medical Sciences (NMS) China Joins Roche Accelerator to Advance Oncology Innovation - NMS Group

Fuente

NMS GROUP S.P.A.

1.00

0

Press Release cover image

07/11/2025

Música

Salud

Sanidad

Nerviano Medical Sciences presented data on novel payload linkers for ADC conjugation at the World ADC Summit 2025 - NMS Group

Fuente

NMS GROUP S.P.A.

1.00

0

Press Release cover image

27/10/2025

Salud

Sanidad

Nerviano Medical Sciences Srl Announces Participation in BIO-Europe 2025 - NMS Group

Fuente

NMS GROUP S.P.A.

1.00

0

Press Release cover image

11/09/2025

Legislación/Derecho

Ingeniería

Ciencia

CPHI Frankfurt 2025 - NMS Group

Fuente

NMS GROUP S.P.A.

1.00

0

Press Release cover image

01/08/2025

Salud

Oncología

Sanidad

Nerviano Medical Sciences Srl Launches China Subsidiary to Advance Oncology Pipeline and ADC Portfolio - NMS Group

Fuente

NMS GROUP S.P.A.

1.00

0

Press Release cover image

28/07/2025

Universidad

Salud

Sanidad

Accelera Appoints Silvia Guionaud, PhD, DECVP, as Chief Executive Officer - NMS Group

Fuente

NMS GROUP S.P.A.

1.00

0

Press Release cover image

28/07/2025

Economía

Finanzas

Universidad

Mercado laboral

BioNerviano Srl Appoints Serena Alvino as Chief Executive Officer - NMS Group

Fuente

NMS GROUP S.P.A.

1.00

0

Press Release cover image

28/07/2025

Salud

Oncología

Sanidad

Fútbol

NerPharMa Appoints Serena Alvino as Chief Executive Officer - NMS Group

Fuente

NMS GROUP S.P.A.

1.00

0

Press Release cover image

23/07/2025

Universidad

Salud

Sanidad

Nerviano Medical Sciences Srl Announces its plan to focus its portfolio on three biological targets and ADC platform - NMS Group

Fuente

NMS GROUP S.P.A.

1.00

0

Seguidores

0

Compatibilidad

0